Context Therapeutics Inc. (CNTX) Live Share Price, Invest From India

Context Therapeutics Inc. Stock Performance

as on July 1, 2026 at 6:59 am IST

Day's High
$0.55
Day's Price Range
$0.61
$0.55
10.91%
Upside
52 Week's Low
52 Week's High
$0.55
52-Week Price Range
$3.62
$0.55
0.89%
Downside
558.18%
Upside

Context Therapeutics Inc. share price movements today

Previous Close: $0.58
Open: $0.57
Volume: 2.8M
Day's Low - High: $0.55 - $0.61
52 Week Low - High: $0.55 - $3.62

Context Therapeutics Inc. Historical Returns

1 Month Return: -79.75 %
3 Month Return: -76.44 %
1 Year Return: -11.92 %
3 Year Return: -63.93 %
5 Year Return: 0 %

Context Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Context Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$53.3M

EPS (TTM)

-0.39

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-43.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-56.19%

Context Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Context Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Context Therapeutics Inc.	BUY	$53.3M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$38.7B	506.87%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$38.9B	73.15%	73.03	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$124.7B	147.81%	29.16	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$66.4B	13.12%	15.46	29.65%	0.58%

Stock Returns calculator for Context Therapeutics Inc. Stock including INR - Dollar returns

The Context Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Context Therapeutics Inc. investment value today

Current value as on today

₹92,046

Returns

-₹7,954

(-7.95%)

Returns from Context Therapeutics Inc. Stock

-₹16,667 (-16.67%)

Dollar Impact

₹8,713 (+8.71%)

Analyst Recommendation on Context Therapeutics Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Context Therapeutics Inc.. Average target price of $5.38

Context Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Context Therapeutics Inc..

What analysts predicted

89.78%UPSIDE

Target Price

$5.38

Current Price

$0.55

Analyzed by

8 Analysts

Target

$5.38

Context Therapeutics Inc. target price $5.38, a slight upside of 89.78% compared to current price of $0.55. According to 8 analysts rating.

Indian Investors' Interest in Context Therapeutics Inc. Stock

Search interest for Context Therapeutics Inc. Stock has increased by 368% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 1, 2026 to July 1, 2026

Change:368% versus previous 30 day period

Context Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	-	-	-	0	0	0	0
Operating Income	-6	-3	-3	-18	-4	-5	-9	-10	-13	-9
EBITDA	-6	-3	-2	-17	-3	-4	-8	-9	-13	-8
Interest Expense	0	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-3	-2	-17	-3	-4	-8	-9	-13	-8
Income Tax Expense	0	0	0	-	-	-	-	-	-	-
Net Income	-6	-3	-2	-17	-3	-4	-8	-9	-13	-8
Net Profit Margin	-35721.22%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Context Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	0	0	0	0
Operating Income	-33	-24	-5	-2	-10	-15	-25	-29	-39
EBITDA	-	-	-5	-2	-10	-14	-23	-26	-36
Interest Expense	-	-	1	0	0	0	-	-	-
Depreciation	-	-	-	-	-	0	0	0	0
Income Before Tax	-37	-25	-6	6	-10	-14	-23	-26	-36
Income Tax Expense	-	0	1	0	-3	0	0	-	-
Net Income	-37	-24	-7	6	-10	-14	-23	-26	-36
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Context Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-3	-2	-17	-3	-4	-8	-9	-13	-8
Operating Cash Flow	-4	-3	-1	-4	-5	-5	-6	-8	-11
Investing Cash Flow	-	-	-14	-	0	-	-	-2	0
Financing Cash Flow	-	94	0	14	0	-	-	-	-
Change in Cash	-4	91	-16	9	-5	-5	-6	-10	-11

Context Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-24	-6	6	-10	-14	-23	-26	-36
Operating Cash Flow	-22	-2	-1	-8	-13	-21	-14	-26
Investing Cash Flow	0	0	0	0	0	-	-14	-2
Financing Cash Flow	66	1	1	58	0	-	109	0
Change in Cash	44	0	0	49	-14	-21	79	-28

Global Institutional Holdings in Context Therapeutics Inc.

Funds	Holdings
Vanguard Group Inc	4.12%
Alyeska Investment Group, L.P.	1.81%
Marshall Wace Asset Management Ltd	3.21%
Susquehanna International Group, LLP	1.19%
Walleye Trading Advisors, LLC	0.14%

See all

Insights on Context Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 423.6% return, outperforming this stock by 435.5%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 620.1% return, outperforming this stock by 684.0%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CNTX stock has moved down by -11.4%

About Context Therapeutics Inc.

Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company's product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.

Organisation	Context Therapeutics Inc.
Headquarters	2001 Market Street, Philadelphia, PA, United States, 19103
Industry	Biotechnology
CEO	Mr. Martin A. Lehr
E-voting on shares	Click here to vote

Key Management of Context Therapeutics Inc.

Name	Title
Dr. Karen Chagin M.D.	Chief Medical Officer
Mr. Martin A. Lehr	Co-Founder, President, CEO & Director
Ms. Jennifer Minai-Azary	CFO & Treasurer
Mr. Alex C. Levit Esq., J.D.	Chief Legal Officer & Corporate Secretary
Mr. Christopher Beck M.B.A.	Senior Vice President of Operations
Mr. Jeffrey Liebman	Associate Director of Accounting
Ms. Jennifer Dashnau M.B.A., Ph.D.	Senior Vice President of Technical Operations

FAQs

What is Context Therapeutics Inc. share price today?

Context Therapeutics Inc. share price today is $0.55 as on July 1, 2026 at 1:29 am IST at the close of the market. Context Therapeutics Inc. share today touched a day high of $0.61 and a low of $0.55.

What is the 52 week high and 52 week low for Context Therapeutics Inc. share?

Context Therapeutics Inc. share touched a 52 week high of $3.62 on March 16, 2026 and a 52 week low of $0.55 on June 25, 2026. Context Therapeutics Inc. stock price today i.e. July 1, 2026 at 1:29 am IST is closed at $0.55,which is 84.81% down from its 52 week high and 0.90% up from its 52 week low.

What is Context Therapeutics Inc.'s market capitalisation today?

Context Therapeutics Inc. market capitalisation is $0.00T as on July 1, 2026 at 1:29 am IST.

How to invest in Context Therapeutics Inc. Stock (CNTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Context Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Context Therapeutics Inc. Shares that will get you 2.7273 shares as per Context Therapeutics Inc. share price of $0.55 per share as on July 1, 2026 at 1:29 am IST.

What is the minimum amount required to buy Context Therapeutics Inc. Stock (CNTX) from India?

Indian investors can start investing in Context Therapeutics Inc. (CNTX) shares with as little as ₹94.66 or $1 (as of July 1, 2026 at 3:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.60 in Context Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on July 1, 2026 at 3:43 am IST). Based on Context Therapeutics Inc. share’s latest price of $0.55 as on July 1, 2026 at 1:29 am IST, you will get 18.1818 shares of Context Therapeutics Inc.. Learn more about fractional shares .